ADIM
ATI icon

Alpha DNA Investment Management’s ATI ATI Stock Holding History

Alpha DNA Investment Management’s Portfolio ATI Stock Details ATI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-43,528
Closed -$988K – 153
2022
Q2 		$988K Buy
+43,528
New +$1.15M 0.84% 62

Other funds holding ATI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
CCM
Channing Capital Management Chicago, Illinois $3.91B AUM 34.32% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Alpha DNA Investment Management's ATI Position: Q3 2022 in Review

Alpha DNA Investment Management sold out of ATI (ATI) in Q3 2022, closing a stake of 43,528 shares — an estimated $988K sold.

Alpha DNA Investment Management first reported a position in ATI in Q2 2022 and held it in 1 quarter. The position peaked at $988K in Q2 2022. 291 funds tracked by Wall St. Rank hold ATI as of Q3 2022.

  • Alpha DNA Investment Management reported no remaining ATI position as of Q3 2022 after selling out during the quarter.
  • Alpha DNA Investment Management sold 43,528 ATI shares in Q3 2022, an estimated $988K.
  • Alpha DNA Investment Management first reported a position in ATI in Q2 2022 and held it in 1 quarter.
  • Alpha DNA Investment Management's ATI position peaked at $988K in Q2 2022.
  • 291 funds tracked by Wall St. Rank held ATI as of Q3 2022.

Based on Alpha DNA Investment Management's 13F filing for Q3 2022, filed 15 Nov 2022.